| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $547.09 | $532.04 | $541.16 | $541.97 |
| Short term investments | ||||
| Net receivables | $17.32 | $17.28 | $18.26 | $24 |
| Inventory | $19.51 | $19.29 | $19.7 | $18.39 |
| Total current assets | $797.64 | $800.45 | $831.04 | $893.99 |
| Long term investments | ||||
| Property, plant & equipment | $26.82 | $26.07 | $27.16 | $28.79 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $908.12 | $910.98 | $973.97 | $1064.34 |
| Current liabilities | ||||
| Accounts payable | $23.68 | $23.31 | $25.96 | $34.43 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $27.84 | $27.01 | $30.41 | $34.47 |
| Long term debt | $7.76 | $8 | $8.28 | $9.34 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $41.49 | $41.34 | $45.55 | $49.56 |
| Shareholders' equity | ||||
| Retained earnings | -$678.3 | -$669.95 | -$625.98 | -$591.21 |
| Other shareholder equity | $1.91 | $0.53 | $0.52 | $3.64 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $541.97 | $346.66 | $853.63 | $585.34 |
| Short term investments | $437.6 | $85.6 | ||
| Net receivables | $22.22 | $10.94 | $7.94 | $1.14 |
| Inventory | $18.39 | $19.4 | $11.2 | $3.31 |
| Total current assets | $893.99 | $1064.32 | $1311.89 | $676.15 |
| Long term investments | $64.37 | |||
| Property, plant & equipment | $28.79 | $22.38 | $12.18 | $8.26 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $13.11 | |||
| Total investments | ||||
| Total assets | $1064.34 | $1203.46 | $1389.95 | $689.26 |
| Current liabilities | ||||
| Accounts payable | $4.7 | $3.72 | $2.83 | $0.78 |
| Deferred revenue | ||||
| Short long term debt | $0.42 | |||
| Total current liabilities | $34.47 | $37.03 | $32 | $6.69 |
| Long term debt | $9.34 | $13.11 | $1.1 | $2.6 |
| Total noncurrent liabilities | $15.45 | |||
| Total debt | ||||
| Total liabilities | $49.56 | $53.93 | $45.72 | $22.14 |
| Shareholders' equity | ||||
| Retained earnings | -$591.21 | -$536.66 | -$309.23 | -$108.46 |
| Other shareholder equity | $3.64 | $3.09 | $1.41 | $1.43 |
| Total shareholder equity | $1343.36 | $667.12 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $14.86 | $14.99 | $13.36 | $14.45 |
| Cost of revenue | ||||
| Gross Profit | $7.16 | $6.83 | $6.18 | $7.03 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $27.43 | $27.64 | $25.14 | $34.29 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.05 | $0.14 | -$0.02 | $0.18 |
| Interest expense | $11.59 | -$23.28 | -$16.01 | $26.11 |
| Net income | ||||
| Net income | -$8.35 | -$43.97 | -$34.77 | -$1.05 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $56.31 | $43.63 | $10.49 | $3.4 |
| Cost of revenue | $5.73 | $1.56 | ||
| Gross Profit | $25.46 | $14.05 | $4.76 | $1.84 |
| Operating activities | ||||
| Research & development | $41.69 | $9.88 | ||
| Selling, general & administrative | $42.36 | $26.88 | ||
| Total operating expenses | $150.34 | $145.05 | $93.41 | $39.1 |
| Operating income | -$82.92 | -$35.7 | ||
| Income from continuing operations | ||||
| EBIT | -$82.92 | -$35.7 | ||
| Income tax expense | $0.06 | $0.26 | -$4.91 | |
| Interest expense | $69.28 | -$56.51 | -$0.24 | -$0.39 |
| Net income | ||||
| Net income | -$54.55 | -$227.42 | -$200.78 | -$48.49 |
| Income (for common shares) | -$200.78 | -$48.49 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $22.89 | $26.22 | $9.06 | -$166.6 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$73.3 | -$72.63 | -$53.18 | -$105.41 |
| Effect of exchange rate | -$0.9 | -$0.69 | -$0.62 | $1.29 |
| Change in cash and equivalents | -$95.91 | -$77.79 | -$57.71 | -$375.79 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | -$200.78 | -$48.49 | ||
| Operating activities | ||||
| Depreciation | $3.74 | $1.89 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$42.58 | -$9.65 | ||
| Investing activities | ||||
| Capital expenditures | -$9.76 | -$1.36 | ||
| Investments | -$416.02 | -$85.5 | ||
| Total cash flows from investing | -$166.6 | -$67.67 | -$496.68 | -$86.76 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$2.31 | -$1.12 | ||
| Total cash flows from financing | -$105.41 | -$5.27 | $804.18 | $677.73 |
| Effect of exchange rate | $1.29 | -$3.26 | $3.37 | $0.13 |
| Change in cash and equivalents | -$375.79 | -$168.26 | $268.29 | $581.44 |
| Market cap | $491.37M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 290.75M |
| Revenue | $57.66M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$88.14M |
| Revenue Q/Q | 22.19% |
| Revenue Y/Y | 6.85% |
| P/E ratio | -5.58 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 8.52 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 1.88 |
| EPS | -$0.30 |
|---|---|
| ROA | -9.14% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 28.65 |
| Quick ratio | 27.95 |